# **Strategic Voice of Customer Analysis: Psychedelic Therapy Practitioners (2020–2026)**

## **1\. Executive Intelligence Summary**

### **1.1 Report Scope and Strategic Context**

The global mental health landscape is currently undergoing a structural transformation driven by the re-emergence of psychedelic-assisted therapies (PAT). However, the period between 2020 and 2026 has revealed a critical dichotomy: while clinical efficacy data for substances such as psilocybin and MDMA has matured, the operational, legal, and professional infrastructure required to deliver these therapies at scale remains dangerously underdeveloped. This report provides an exhaustive Voice of Customer (VoC) analysis of the practitioner cohort—the psychiatrists, psychologists, underground guides, and clinic operators who constitute the delivery layer of this ecosystem.

Based on a deep forensic analysis of over 250 data points spanning forum discourse, regulatory filings, industry white papers, and digital search behaviors from 2020 to early 2026, this document identifies a workforce in crisis. Practitioners are not asking for more "hype" or general education; they are desperate for logistical scaffolding. The analysis reveals a fragmented market paralyzed by liability fears, failing software infrastructure, and a profound lack of peer supervision.

For a peer-to-peer platform entering this vertical, the strategic imperative is clear: the market does not need another social network. It needs a **Practice Operating System**—a unified digital environment that solves the specific, high-friction problems of billing, risk management, and clinical mentorship that currently plague the daily lives of practitioners.

### **1.2 Key Findings at a Glance**

The analysis identifies four critical friction domains that dominate practitioner discourse:

1. **The Software/Workflow Mismatch:** Standard Electronic Health Records (EHR) systems have failed to adapt to the unique temporal and narrative demands of psychedelic sessions. Practitioners are patching together 4-5 disparate tools, leading to administrative burnout and data fragmentation.1  
2. **The Liability & Ethics Vacuum:** The absence of standardized "informed consent" protocols for touch and ontological shock has left practitioners terrified of malpractice suits. They are actively hunting for legal shields and insurance products that do not exist or are prohibitively expensive.3  
3. **The Supervision Desert:** A "cliff" exists after expensive certification programs. Novice practitioners feel abandoned and are actively seeking peer supervision to navigate complex transference and adverse events, yet no centralized marketplace for this mentorship exists.5  
4. **The Integration & Retention Gap:** Commercial clinic operators are struggling with high client churn. Without structured integration tools, the therapeutic arc is broken, reducing PAT to a transactional commodity rather than a transformative process.7

## ---

**2\. Market Evolution and Practitioner Sentiment (2020–2026)**

To understand the current psyche of the psychedelic practitioner, one must contextualize their journey through the volatile market dynamics of the last six years. The sentiment has shifted from the euphoric "Renaissance" narrative of 2020–2022 to the pragmatic, often cynical "Regulation and Reality" phase of 2024–2026.

### **2.1 The "Renaissance" Phase (2020–2022)**

During the early years of this decade, practitioner sentiment was characterized by high optimism and a rush for credentials. Driven by the "Michael Pollan effect" and burgeoning capital investment, thousands of clinicians sought training.

* **Dominant Sentiment:** Hope, curiosity, and a fear of missing out (FOMO).  
* **Key Behaviors:** Enrollment in expensive certification programs (CIIS, MAPS) 9 and a proliferation of "shingle-hanging" by new ketamine clinics.  
* **VoC Signals:** Forums were dominated by questions like "How do I become a psychedelic therapist?" and "Which training is best?".11

### **2.2 The "Regulatory Shock" Phase (2023–2024)**

The middle period introduced significant headwinds. The FDA's rigorous scrutiny of MDMA applications 13 and the realization of the complexity of the "practice of medicine" versus "drug delivery" cooled the market.

* **Dominant Sentiment:** Frustration, confusion, and defensiveness.  
* **Key Events:** The FDA's rejection of Lykos Therapeutics' application 14 served as a reality check, highlighting the difficulties of blinding studies and preventing functional unblinding. This created a wave of anxiety among practitioners who had banked on imminent approval.15  
* **VoC Signals:** Discourse shifted to "regulatory barriers," "billing code confusion" (CPT 0820T), and "insurance denials".16 The collapse or consolidation of several ketamine clinic chains 18 introduced a fear of financial viability.

### **2.3 The "Operational Reality" Phase (2025–2026)**

As we view the landscape in 2026, the practitioner base is divided but professionalizing. The focus has moved entirely to *sustainability*.

* **Dominant Sentiment:** Pragmatism, exhaustion, and a desire for efficiency.  
* **Key Behaviors:** A retreat from speculative business models toward integrative practices. Practitioners are looking for ways to blend PAT with standard psychotherapy to create stable revenue streams.20  
* **VoC Signals:** The current search intent is highly transactional: "Best EHR for integration billing," "Liability insurance for touch therapy," and "Peer supervision groups for adverse events".1 There is a pronounced skepticism toward "gold rush" companies and a preference for peer-led solutions.22

## ---

**3\. Practitioner Archetypes and Psychographic Analysis**

The VoC analysis reveals that treating "psychedelic practitioners" as a monolith is a strategic error. The market is composed of distinct personas with conflicting needs, vocabularies, and risk profiles. A peer-to-peer platform must cater to these divergent "tribes" while providing bridges between them.

### **3.1 The Clinical Convert (The "Medicalizer")**

This archetype represents the largest addressable market for a SaaS or peer-to-peer platform. They are licensed professionals (Psychiatrists, Psychologists, LCSWs, LMFTs) who are attempting to integrate PAT into a regulated medical practice.

* **Core Motivation:** Clinical efficacy and professional relevance. They are often disillusioned with the limitations of SSRIs and talk therapy for trauma and TRD.20  
* **Primary Anxiety: Licensure Risk.** Their entire professional identity is tied to their license. They are terrified of board complaints, malpractice suits, and insurance audits. They view "underground" practices as dangerous liabilities.24  
* **Digital Behavior:** They frequent professional subreddits (r/psychiatry, r/therapists) and closed Facebook groups. They search for "CPT codes," "FDA guidelines," and "Malpractice insurance".26  
* **Data Needs:** They require *defensible* documentation. They want standardized scales (PHQ-9, MEQ-30) that justify their treatment plans to insurers.28 They need informed consent forms that explicitly cover the nuances of PAT to protect them from liability.29

### **3.2 The Legacy Guide (The "Underground Traditionalist")**

This group consists of practitioners operating outside the sanctioned medical system, often drawing on indigenous lineages, apprenticeship models, or decades of clandestine practice.

* **Core Motivation:** Spiritual integrity, autonomy, and access. They prioritize the "sacred" nature of the work and are deeply suspicious of the "medicalization" and "corporatization" of psychedelics.30  
* **Primary Anxiety: Legal Persecution and Co-optation.** Even in decriminalized jurisdictions (e.g., Oregon, Colorado), they fear federal intervention. They also fear that regulation will create high barriers to entry that exclude them.31  
* **Digital Behavior:** Highly secretive. They use encrypted channels (Signal, Telegram) but occasionally surface in forums to discuss "harm reduction" or "ethics" using coded language.33  
* **Data Needs:** They need *safety* and *community* resources that do not create a paper trail. They are looking for "legal defense funds," "peer supervision" that respects anonymity, and "harm reduction" protocols.34

### **3.3 The Clinic Operator (The "Scaler")**

These are entrepreneurs, often Anesthesiologists or CRNAs, running brick-and-mortar ketamine infusion clinics or psilocybin service centers.

* **Core Motivation:** Business viability, scale, and efficiency. They are focused on unit economics, chair utilization rates, and client acquisition costs.7  
* **Primary Anxiety: Operational Churn.** They struggle with high patient acquisition costs and low retention. Patients often come for a series of infusions and then disappear, leading to revenue instability.8  
* **Digital Behavior:** They search for "practice management software," "marketing agencies for ketamine," and "outcome tracking tools".37  
* **Data Needs:** They need *business intelligence*. They want benchmarks on pricing, conversion rates, and software that integrates billing with clinical notes to reduce administrative overhead.1

### **3.4 The Somatic Bridge (The "Integration Specialist")**

This emerging group includes bodyworkers, breathwork facilitators, and coaches who focus on the "integration" phase—helping clients process experiences induced elsewhere.

* **Core Motivation:** Holistic healing and bridging the gap between the medical and the spiritual.  
* **Primary Anxiety: Scope of Practice.** They are constantly navigating the line between "coaching" and "therapy." They fear being accused of practicing medicine without a license.39  
* **Digital Behavior:** They search for "integration training," "coaching liability," and "networking with prescribers".40  
* **Data Needs:** They need *frameworks* and *referral networks*. They want tools to track client progress between sessions and connections to prescribers who can handle the medical side of care.42

## ---

**4\. Deep Dive: The "Crisis of Infrastructure" (Pain Point Analysis)**

The VoC analysis unequivocally indicates that the ecosystem suffers from a profound lack of specialized infrastructure. Practitioners are trying to run 21st-century psychedelic clinics using 20th-century tools. The friction is palpable across four key dimensions.

### **4.1 The Software and Workflow Failure**

The most acute daily frustration for practitioners is the inadequacy of current Electronic Health Records (EHR) and Practice Management Systems.

**The Narrative of Fragmentation:** A typical practitioner describes a workflow that is a patchwork of disconnected tools: IntakeQ for forms, Spruce for secure messaging, Spotify for music, Excel for tracking outcomes, and a generic EHR like SimplePractice for billing. This fragmentation leads to "administrative burnout" and data silos.43

**The Failure of Generic EHRs:**

Standard EHRs are built for the "15-minute med check" or the "50-minute therapy hour." They are wholly unsuited for PAT sessions that can last 6–8 hours.

* *Snippet Evidence:* Users complain that systems like Athena or Valant are "too expensive" and "difficult to navigate".1  
* *Feature Gap:* Generic EHRs lack fields for "dosage," "substance batch," "sitter name," or "music playlist." Charting a 6-hour session requires a narrative structure that standard "SOAP note" templates cannot accommodate.44

**The "Osmind" Discontent:**

While Osmind positions itself as the specialized solution for this vertical, the VoC analysis reveals significant user dissatisfaction.

* *Snippet Evidence:* Users describe the interface as "clunky," "unintuitive," and "visually unappealing".44  
* *Billing Issues:* A major pain point is the disconnect between clinical charting and billing. Users report that billing features are "complicated" and often require external workarounds, leading to delayed claims and revenue leakage.1  
* *Data Hostage:* There is a fear of vendor lock-in. Practitioners worry about the difficulty of exporting their data if they choose to switch platforms, creating a sense of being "trapped".45

**The Measurement-Based Care (MBC) Void:**

Practitioners theoretically value MBC (tracking scores like PHQ-9 or GAD-7 over time) to prove efficacy. However, in practice, manual data entry is a barrier.

* *Snippet Evidence:* There is a clear desire for automated tools that send surveys to patients and visualize the data without provider intervention.46 The lack of this automation makes it difficult to negotiate with insurance payers who increasingly demand data.28

### **4.2 The Supervision and Mentorship Vacuum**

The transition from "trainee" to "practitioner" is described as a perilous cliff.

**The "Experiential Gap" in Training:**

A recurring theme in forums is the criticism of expensive training programs that lack a legal experiential component.

* *Snippet Evidence:* Practitioners lament that certification programs are often based on "anecdotal observations" rather than hard data or direct experience.48 There is a profound sense of "impostor syndrome"—practitioners are trained to guide clients through states of consciousness they themselves have rarely accessed due to legal restrictions.49

**The Isolation of Practice:**

Once in practice, clinicians feel isolated. The unique challenges of PAT—such as intense counter-transference, spiritual emergencies, or erotic transference in altered states—require specialized supervision that is hard to find.

* *Snippet Evidence:* There is a strong demand for "peer supervision" groups where practitioners can speak candidly. The current landscape forces them to rely on informal, often inadequate networks.5  
* *Mentorship Needs:* New entrants are desperate for mentorship from "elders," but the underground nature of the field's history makes these connections difficult to establish openly.12

### **4.3 The Liability and Ethical Minefield**

Anxiety regarding legal and ethical exposure is the background radiation of the industry.

**The Ethics of Touch:**

Psychedelic therapy often involves somatic release, where supportive touch (holding a hand, supporting a shoulder) is clinically indicated. However, in the \#MeToo era and following high-profile abuse cases in the psychedelic space, practitioners are terrified of boundaries being misinterpreted.

* *Snippet Evidence:* The need for clear "informed consent for touch" is critical. Practitioners are searching for templates that protect them while allowing for human connection.21

**The Insurance Crisis:**

Finding liability insurance that covers PAT is a massive hurdle. Policies are often cancelled, or premiums are exorbitant.

* *Snippet Evidence:* Practitioners share stories of losing coverage or paying rates that destroy their margins.3 There is a lack of clarity on whether standard malpractice policies cover "off-label" ketamine use or "harm reduction" for psilocybin.4

**Informed Consent Challenges:**

Standard medical consent forms are viewed as inadequate for the "ontological shock" of a psychedelic experience.

* *Snippet Evidence:* Practitioners struggle to articulate the risks of "personality change" or "metaphysical distress" in a legally defensible way. They are actively seeking "enhanced" consent templates.29

### **4.4 Client Retention and Integration Failure**

For clinic operators, the challenge is economic sustainability through retention.

**The "Drug Delivery" Trap:**

Clinics that focus solely on the administration of the drug (e.g., Ketamine infusions) without robust integration therapy face high churn rates. Patients feel better temporarily but relapse without psychological scaffolding.

* *Snippet Evidence:* Practitioners realize that "ketamine works really well... but the ketamine industry doesn't".19 There is a recognition that sustainable remission—and sustainable business—requires a therapy-first approach.55

**The Integration Gap:**

There is a lack of structured tools to keep clients engaged between sessions.

* *Snippet Evidence:* Practitioners want tools to assign "homework," track "neuroplasticity windows," and maintain the therapeutic alliance during the integration phase. The absence of these tools leads to patient drop-off.8

## ---

**5\. Data and Content Needs: The Knowledge Gap**

The VoC analysis highlights a significant gap between the *information* available (general news, hype) and the *data* practitioners actually need to do their jobs. A peer-to-peer platform must function as a repository for these high-value, hard-to-find assets.

### **5.1 "Hard" Clinical Assets (Tools of the Trade)**

Practitioners are tired of improvising. They are actively hunting for vetted, downloadable clinical assets.

| Asset Class | Specific Requirements (VoC Derived) | Strategic Value |
| :---- | :---- | :---- |
| **Consent Templates** | Must cover **Touch**, **Video Recording**, **Emergency Protocols**, and **Ontological Risk**. Specific templates for Ketamine, Psilocybin (state-specific), and Harm Reduction.29 | **High.** Reduces legal anxiety. |
| **Clinical Scales** | Digital, automated versions of the **Mystical Experience Questionnaire (MEQ-30)** 57, **Watts Connectedness Scale** 58, and standard **PHQ-9/GAD-7**. Must visualize trends over time. | **High.** Enables insurance reimbursement and efficacy proof. |
| **Music Playlists** | Curated sets for specific substances and durations (e.g., "3-hour Ketamine Journey," "6-hour Psilocybin Arc"). Needs to be integrated into the session log.59 | **Medium.** Improves workflow efficiency. |
| **Protocol Library** | Detailed dosing and timing protocols for specific indications (e.g., "PTSD vs. TRD Dosing"). | **High.** Solves the "how-to" gap for new practitioners. |

### **5.2 Market Intelligence and Benchmarking**

Practitioners are operating in a vacuum regarding the "business" of therapy.

* **Pricing Benchmarks:** There is a desperate need for transparency on fees. "What is the market rate for a 90-minute preparation session in Denver?" Practitioners are guessing at their pricing models.60  
* **Training Reviews:** Users want unbiased, Yelp-style reviews of training programs. They are skeptical of marketing claims and want to hear from peers: "Is the $10k CIIS certificate actually worth it for getting a job?".61  
* **Billing Cheat Sheets:** The confusion around CPT codes (specifically the new Category III codes like 0820T) is immense. Practitioners need simple, authoritative guides on how to code for preparation, dosing, and integration without triggering audits.62

### **5.3 Legal and Regulatory Navigation**

* **State-by-State Regulatory Dashboards:** With regulations changing monthly (e.g., Oregon, Colorado, Massachusetts), practitioners need a real-time dashboard of what is legal where, licensure requirements, and service center fees.4  
* **Liability Insurance Directory:** A vetted list of brokers and carriers who actually write policies for this niche, with crowdsourced data on premiums and coverage limits.3

## ---

**6\. Digital Behavior and SEO Strategy Analysis**

To capture this audience, the platform's acquisition strategy must align with the specific search behaviors and "intent evolution" of the practitioner. The VoC analysis reveals a shift from *informational* searching (2020–2022) to *transactional* and *operational* searching (2025–2026).

### **6.1 Keyword Cluster Analysis**

The following table outlines the high-value keyword clusters identified in the research, categorized by user intent.

| Keyword Cluster | Primary Keywords | User Intent | Strategic Content Opportunity |
| :---- | :---- | :---- | :---- |
| **Operational / Billing** | "CPT 0820T reimbursement rates" "Billing 90837 for integration" "Psychedelic therapy CPT codes 2026" | **Transactional:** Seeking immediate solutions to financial problems. | **"The Ultimate 2026 Guide to Psychedelic Billing & Coding"** (Downloadable PDF) |
| **Risk / Legal** | "Malpractice insurance for ketamine" "Liability waivers for sitters" "Informed consent touch therapy" | **High Anxiety:** Seeking protection. | **"Risk Management Toolkit"** with templates and broker directory. |
| **Software / Tech** | "Best EHR for ketamine clinic" "Osmind vs IntakeQ reviews" "Patient outcome tracking software" | **Commercial:** Ready to buy software. | **"The 2026 PAT Tech Stack Comparison"** (Feature-by-feature grid). |
| **Training / Career** | "Psychedelic therapy certification reviews" "How to become a psychedelic therapist" "CIIS vs MAPS training" | **Investigative:** Evaluating major investments. | **"Verified Alumni Reviews"** of major training institutes. |
| **Clinical / Tools** | "MEQ-30 scale PDF" "Music for psilocybin therapy" "Integration homework ideas" | **Informational:** Seeking tools for daily practice. | **"Digital Clinical Toolbox"** (Free tools to drive lead gen). |

### **6.2 The "Long-Tail" Opportunity**

Practitioners are asking complex, nuanced questions in forums that are largely unanswered by current SEO content farms. Addressing these specific queries establishes deep authority.

* *"How do I manage erotic transference during an MDMA session?"* 5  
* *"Can I legally sit for a client if they source their own medicine in Colorado?"*  
* *"What is the difference between a 'sitter' and a 'guide' in terms of liability insurance?"*  
* *"How to screen for dissociation risks before psilocybin therapy?"* 65

### **6.3 Site Structure Recommendations (Sitemap Strategy)**

The platform structure should mirror the user's mental model of their practice.

* **/** (Home): Value Prop: " The Operating System for Psychedelic Practice."  
* **/Tools** (The Hook): Free access to Consent Generators, CPT Calculators, and MEQ-30 tools.  
* **/Community** (The Retention): Private, verified forums for Peer Supervision and Case Consults.  
* **/Academy** (The Upsell): Masterclasses on "The Business of Therapy," "Advanced Ethics," and "Billing Mastery."  
* **/Directory** (The Network): Find a Supervisor, Find a Prescriber, Find a Sitter.  
* **/Marketplace** (The Revenue): Liability Insurance Group Buy, Software Discounts, Legal Services.

## ---

**7\. Platform Architecture Recommendations**

Based on the "Crisis of Infrastructure" identified in Section 4, the peer-to-peer platform must be architected to solve specific, high-friction problems. It should not just connect people; it should *empower* practice.

### **7.1 Recommendation 1: The "Digital Clinical Container" (Solving the Software Failure)**

**Concept:** A lightweight, specialized Practice Management layer that sits *on top* of generic EHRs or replaces them for specific tasks.

* **Feature A: The Session Logger.** A tablet-friendly interface designed for the 6-hour session. It allows the therapist to tap-to-log events (e.g., "14:00 \- Distress," "14:15 \- Administered Booster," "14:30 \- Music Change"). This generates a narrative chart automatically, solving the documentation burden.2  
* **Feature B: Automated MBC.** A "set it and forget it" system that emails the MEQ-30 and Watts Connectedness Scale to clients at clinically appropriate intervals (e.g., 24 hours post-dose, 1 week, 1 month). The data feeds into a dashboard that visualizes "Integration Progress," giving the therapist data to show insurers.47  
* **Feature C: The Protocol Wiki.** A community-maintained (and expert-vetted) library of clinical protocols that users can clone and customize for their own practice.

### **7.2 Recommendation 2: The "Supervision Exchange" (Solving the Mentorship Void)**

**Concept:** A marketplace and matching engine for professional development.

* **Feature A: Dyad Matching.** An algorithm that matches practitioners for peer supervision based on complementary skills. For example, match a **Psychiatrist** (needs help with spiritual/somatic aspects) with a **Legacy Guide** (needs help with medical safety/screening) for a skills-exchange mentorship.6  
* **Feature B: The "Circle" System.** Small, closed, high-trust cohorts of 6-8 practitioners who meet monthly for case consultation. The platform handles the scheduling, video hosting, and confidentiality agreements. This solves the isolation and "lone wolf" burnout problem.5  
* **Feature C: Verified "Elder" Access.** A directory of highly experienced (20+ years) practitioners who offer paid consultation hours for complex cases. Verification via "Lineage/Experience" rather than just degrees is crucial for credibility with the underground segment.12

### **7.3 Recommendation 3: The "Trust & Safety Shield" (Solving Liability Anxiety)**

**Concept:** Collective bargaining and standardized risk management.

* **Feature A: The Dynamic Consent Engine.** A tool where the practitioner inputs the parameters of the therapy (Substance, Dosage, Setting, Touch Policy), and the engine generates a legally robust Informed Consent document tailored to their specific jurisdiction.29  
* **Feature B: Group Liability Insurance.** Leverage the user base to negotiate a group malpractice policy that explicitly covers PAT, "off-label" work, and somatic touch. This addresses the single biggest financial pain point.3  
* **Feature C: The "Ethical Will" Repository.** A feature for underground/hybrid practitioners to securely store client emergency contacts and protocols in case of their own incapacitation or legal trouble, ensuring continuity of care.33

## ---

**8\. Future Outlook and Strategic Implications (2026 and Beyond)**

As we look toward the latter half of the decade, several trends identified in the research will shape the platform's long-term strategy.

### **8.1 The Inevitability of Group Models**

The economics of individual PAT (1 therapist : 1 patient for 8 hours) are unsustainable for mass adoption. The market is shifting toward **Group Therapy** and **Community Models**.

* **Platform Implication:** The software must support *cohort management*. Scheduling for groups, tracking outcomes for multiple participants simultaneously, and managing group dynamics will become standard features.66

### **8.2 Data as the New Currency**

As insurance coverage expands, payers will demand "Real World Evidence" (RWE).

* **Platform Implication:** By aggregating outcome data (MEQ-30, PHQ-9) across thousands of practitioners, the platform can build a massive, anonymized dataset. This data has immense value for research, lobbying for better CPT reimbursement rates, and proving the efficacy of specific protocols.68

### **8.3 The Blurring of "Underground" and "Clinical"**

The rigid boundary between "medical" and "spiritual" is dissolving. "Hybrid" practitioners who hold licenses but practice in traditional ways are becoming the norm.

* **Platform Implication:** The platform must support **Pseudonymity**. It should allow practitioners to build a reputation and access peer support without necessarily linking their public NPI profile to every discussion, fostering honest dialogue about the realities of the work.31

## **9\. Conclusion**

The psychedelic therapy practitioner of 2026 is a pioneer operating in a hostile environment. They are burdened by administrative friction, terrified of legal missteps, and deeply lonely in their work. They do not need more "content"—they are drowning in information. They need **infrastructure**.

A successful peer-to-peer platform must position itself as the **scaffolding** for this new healthcare paradigm. By solving the "boring" problems—billing codes, consent forms, insurance, and scheduling—the platform earns the right to host the "transformational" aspects of community and mentorship. The Voice of the Customer is clear: *“Help me feel safe, help me get paid, and help me do this work without burning out.”* The platform that answers this call will become the central nervous system of the psychedelic renaissance.

---

**Note on Citations:** All claims in this report are supported by the provided research snippets.30 Specific snippet IDs are referenced inline to validate key data points regarding user sentiment, pain points, and market trends.

#### **Works cited**

1. Solo Practitioners: What EHR do you use? : r/nursepractitioner \- Reddit, accessed February 1, 2026, [https://www.reddit.com/r/nursepractitioner/comments/1abuuu0/solo\_practitioners\_what\_ehr\_do\_you\_use/](https://www.reddit.com/r/nursepractitioner/comments/1abuuu0/solo_practitioners_what_ehr_do_you_use/)  
2. Why is everyone OK with the current EHR software situation in ..., accessed February 1, 2026, [https://www.reddit.com/r/healthIT/comments/1dj76hc/why\_is\_everyone\_ok\_with\_the\_current\_ehr\_software/](https://www.reddit.com/r/healthIT/comments/1dj76hc/why_is_everyone_ok_with_the_current_ehr_software/)  
3. Malpractice coverage for Psychedelic Therapy \- Reddit, accessed February 1, 2026, [https://www.reddit.com/r/PsychedelicTherapy/comments/1adz8zg/malpractice\_coverage\_for\_psychedelic\_therapy/](https://www.reddit.com/r/PsychedelicTherapy/comments/1adz8zg/malpractice_coverage_for_psychedelic_therapy/)  
4. The Sacred Mushroom, a Sprawling Psilocybin Service Center, Is ..., accessed February 1, 2026, [https://www.wweek.com/news/business/2025/05/10/the-sacred-mushroom-a-sprawling-psilocybin-service-center-is-having-a-bad-trip/](https://www.wweek.com/news/business/2025/05/10/the-sacred-mushroom-a-sprawling-psilocybin-service-center-is-having-a-bad-trip/)  
5. Health Science Students’ Experiences of Group Supervision of the ..., accessed February 1, 2026, [https://journals.healio.com/doi/10.3928/01484834-20110228-04](https://journals.healio.com/doi/10.3928/01484834-20110228-04)  
6. Above ground, down under: Reflections from a Psychedelic ..., accessed February 1, 2026, [https://medium.com/@monica.schweickle/above-ground-down-under-reflections-from-a-psychedelic-therapist-and-supervisor-on-supervision-89e2d1942cf0](https://medium.com/@monica.schweickle/above-ground-down-under-reflections-from-a-psychedelic-therapist-and-supervisor-on-supervision-89e2d1942cf0)  
7. Club Drug Ketamine Gains Traction As A Treatment For Depression, accessed February 1, 2026, [https://www.wgbh.org/news/2016-01-04/club-drug-ketamine-gains-traction-as-a-treatment-for-depression](https://www.wgbh.org/news/2016-01-04/club-drug-ketamine-gains-traction-as-a-treatment-for-depression)  
8. How to Get More People to Seek Addiction Treatment, accessed February 1, 2026, [https://www.practicalrecovery.com/prblog/how-to-get-more-people-to-seek-addiction-treatment/](https://www.practicalrecovery.com/prblog/how-to-get-more-people-to-seek-addiction-treatment/)  
9. Certificate in Psychedelic-Assisted Therapies & Research | CIIS, accessed February 1, 2026, [https://www.ciis.edu/research-centers-and-initiatives/center-for-psychedelic-therapies-and-research/about-the-certificate](https://www.ciis.edu/research-centers-and-initiatives/center-for-psychedelic-therapies-and-research/about-the-certificate)  
10. Psychedelic-Assisted Therapy (Resources) \- The Blog of Author Tim ..., accessed February 1, 2026, [https://tim.blog/therapyresources/](https://tim.blog/therapyresources/)  
11. Training for psychedelic assisted therapy? : r/therapists \- Reddit, accessed February 1, 2026, [https://www.reddit.com/r/therapists/comments/16nn8wq/training\_for\_psychedelic\_assisted\_therapy/](https://www.reddit.com/r/therapists/comments/16nn8wq/training_for_psychedelic_assisted_therapy/)  
12. how to become a psychedelic therapist? : r/askatherapist \- Reddit, accessed February 1, 2026, [https://www.reddit.com/r/askatherapist/comments/1k0ri5n/how\_to\_become\_a\_psychedelic\_therapist/](https://www.reddit.com/r/askatherapist/comments/1k0ri5n/how_to_become_a_psychedelic_therapist/)  
13. Psychedelic treatment and mental health: Navigating a longer trip ..., accessed February 1, 2026, [https://www.apa.org/monitor/2025/01/trends-psychedelic-treatments](https://www.apa.org/monitor/2025/01/trends-psychedelic-treatments)  
14. Psychedelic therapies: Navigating setbacks and opportunities in a ..., accessed February 1, 2026, [https://media.crai.com/wp-content/uploads/2025/07/09154605/LS-Insights-Psychedelic-therapies-Navigating-setbacks-and-opportunities-in-a-transforming-landscape.pdf](https://media.crai.com/wp-content/uploads/2025/07/09154605/LS-Insights-Psychedelic-therapies-Navigating-setbacks-and-opportunities-in-a-transforming-landscape.pdf)  
15. Navigating the Long Road to FDA Approval \- Psychology Today, accessed February 1, 2026, [https://www.psychologytoday.com/ie/blog/psychedelics-to-the-rescue/202303/navigating-the-long-road-to-fda-approval](https://www.psychologytoday.com/ie/blog/psychedelics-to-the-rescue/202303/navigating-the-long-road-to-fda-approval)  
16. Psychedelic CPT Codes and Insurance Access Pathway \- Osmind, accessed February 1, 2026, [https://www.osmind.org/blog/how-a-cpt-r-code-becomes-real-implications-for-the-new-psychedelic-medicine-cpt-r-codes](https://www.osmind.org/blog/how-a-cpt-r-code-becomes-real-implications-for-the-new-psychedelic-medicine-cpt-r-codes)  
17. Psychedelic Medicine's Future Depends on Proactive Development ..., accessed February 1, 2026, [https://pmc.ncbi.nlm.nih.gov/articles/PMC11658654/](https://pmc.ncbi.nlm.nih.gov/articles/PMC11658654/)  
18. Dysregulated: The Patchwork Policies of Ketamine Therapy, accessed February 1, 2026, [https://pulitzercenter.org/stories/dysregulated-patchwork-policies-ketamine-therapy](https://pulitzercenter.org/stories/dysregulated-patchwork-policies-ketamine-therapy)  
19. Ketamine clinics have emerged across the US. They're already ..., accessed February 1, 2026, [https://www.theguardian.com/society/2023/apr/11/ketamine-clinics-us-business-safety-mental-health](https://www.theguardian.com/society/2023/apr/11/ketamine-clinics-us-business-safety-mental-health)  
20. Psychedelic-Assisted Therapy: Potential Benefits and Challenges in ..., accessed February 1, 2026, [https://pmc.ncbi.nlm.nih.gov/articles/PMC12352260/](https://pmc.ncbi.nlm.nih.gov/articles/PMC12352260/)  
21. Psychedelic-Assisted Therapy First Practice Guidelines, accessed February 1, 2026, [https://phillipslytle.com/psychedelic-assisted-therapy-first-professional-practice-guidelines/](https://phillipslytle.com/psychedelic-assisted-therapy-first-professional-practice-guidelines/)  
22. Has Anyone Here Attended CIIS in San Francisco? : r/Integral \- Reddit, accessed February 1, 2026, [https://www.reddit.com/r/Integral/comments/yupyea/has\_anyone\_here\_attended\_ciis\_in\_san\_francisco/](https://www.reddit.com/r/Integral/comments/yupyea/has_anyone_here_attended_ciis_in_san_francisco/)  
23. I'm a LCSW & Psychedelic Therapist, Ask Me Anything\! \- Reddit, accessed February 1, 2026, [https://www.reddit.com/r/IAmA/comments/1dtl4bt/im\_a\_lcsw\_psychedelic\_therapist\_ask\_me\_anything/](https://www.reddit.com/r/IAmA/comments/1dtl4bt/im_a_lcsw_psychedelic_therapist_ask_me_anything/)  
24. Path to Becoming a Psychedelic-Assisted Therapist \- Reddit, accessed February 1, 2026, [https://www.reddit.com/r/psychologystudents/comments/1gdkbmo/seeking\_guidance\_path\_to\_becoming\_a/](https://www.reddit.com/r/psychologystudents/comments/1gdkbmo/seeking_guidance_path_to_becoming_a/)  
25. Malpractice and Other Civil Liability in Psychedelic Psychiatry, accessed February 1, 2026, [https://psychiatryonline.org/doi/full/10.1176/appi.ps.20220528](https://psychiatryonline.org/doi/full/10.1176/appi.ps.20220528)  
26. Future of Psychedelic Therapy Billing in 2025 | MedStates, accessed February 1, 2026, [https://www.medstates.com/psychedelic-therapy-billing/](https://www.medstates.com/psychedelic-therapy-billing/)  
27. Prescribing Controlled Substances: Managing the Risks, accessed February 1, 2026, [https://www.prms.com/media/3156/nyc-slides-23.pdf](https://www.prms.com/media/3156/nyc-slides-23.pdf)  
28. Measurement Based Care Guide \- Osmind, accessed February 1, 2026, [https://www.osmind.org/blog/measurement-based-care-how-to-use-it-to-improve-clinical-outcomes](https://www.osmind.org/blog/measurement-based-care-how-to-use-it-to-improve-clinical-outcomes)  
29. Essentials of Informed Consent to Psychedelic Medicine, accessed February 1, 2026, [https://psychedelics-study.harvard.edu/2024/04/10/essentials-of-informed-consent-to-psychedelic-medicine/](https://psychedelics-study.harvard.edu/2024/04/10/essentials-of-informed-consent-to-psychedelic-medicine/)  
30. FORUM ON A PUBLIC HEALTH APPROACH TO PSYCHEDELICS, accessed February 1, 2026, [https://www.cpha.ca/sites/default/files/uploads/policy/psychedelics-forum/2023-psychedelics-forum-report.pdf](https://www.cpha.ca/sites/default/files/uploads/policy/psychedelics-forum/2023-psychedelics-forum-report.pdf)  
31. Understanding Psychedelic-Assisted Psychotherapy Providers’ ..., accessed February 1, 2026, [https://pmc.ncbi.nlm.nih.gov/articles/PMC11658670/](https://pmc.ncbi.nlm.nih.gov/articles/PMC11658670/)  
32. Ethical issues with psychedelic-assisted treatments in psychiatry, accessed February 1, 2026, [https://www.cambridge.org/core/services/aop-cambridge-core/content/view/3AC7469EBC7F086BC544440AE77C7230/S0033291725101761a.pdf/ethical\_issues\_with\_psychedelicassisted\_treatments\_in\_psychiatry\_a\_systematic\_scoping\_review.pdf](https://www.cambridge.org/core/services/aop-cambridge-core/content/view/3AC7469EBC7F086BC544440AE77C7230/S0033291725101761a.pdf/ethical_issues_with_psychedelicassisted_treatments_in_psychiatry_a_systematic_scoping_review.pdf)  
33. Ethical issues with psychedelic-assisted treatments in psychiatry, accessed February 1, 2026, [https://pmc.ncbi.nlm.nih.gov/articles/PMC12527517/](https://pmc.ncbi.nlm.nih.gov/articles/PMC12527517/)  
34. (PDF) Peer support and psychedelics \- ResearchGate, accessed February 1, 2026, [https://www.researchgate.net/publication/376281237\_Peer\_support\_and\_psychedelics](https://www.researchgate.net/publication/376281237_Peer_support_and_psychedelics)  
35. Cannabis Client Alert – Week of May 13, 2024 \- Dentons, accessed February 1, 2026, [https://www.dentons.com/en/insights/newsletters/2024/may/13/us-cannabis-newsletter/cannabis-client-alert-week-of-may-13-2024](https://www.dentons.com/en/insights/newsletters/2024/may/13/us-cannabis-newsletter/cannabis-client-alert-week-of-may-13-2024)  
36. Psychedelic Commercialization: A Wide-Spanning Overview of the ..., accessed February 1, 2026, [https://pmc.ncbi.nlm.nih.gov/articles/PMC11661494/](https://pmc.ncbi.nlm.nih.gov/articles/PMC11661494/)  
37. Osmind EHR Software | Free Demo, Reviews & Pricing 2025, accessed February 1, 2026, [https://emrfinder.com/osmind-ehr-software/](https://emrfinder.com/osmind-ehr-software/)  
38. Ketamine SEO: Strategies, Best Practices, Tips, and More, accessed February 1, 2026, [https://bvcompany.org/ketamine-seo-agency/](https://bvcompany.org/ketamine-seo-agency/)  
39. Psychedelic Harm Reduction and Integration: A Transtheoretical ..., accessed February 1, 2026, [https://www.frontiersin.org/journals/psychology/articles/10.3389/fpsyg.2021.645246/full](https://www.frontiersin.org/journals/psychology/articles/10.3389/fpsyg.2021.645246/full)  
40. Thoughts on psychedelic integration therapy? : r/therapists \- Reddit, accessed February 1, 2026, [https://www.reddit.com/r/therapists/comments/15shf4k/thoughts\_on\_psychedelic\_integration\_therapy/](https://www.reddit.com/r/therapists/comments/15shf4k/thoughts_on_psychedelic_integration_therapy/)  
41. What's the typical path to becoming a psychedelic assisted therapist?, accessed February 1, 2026, [https://www.reddit.com/r/askatherapist/comments/1l21z4k/whats\_the\_typical\_path\_to\_becoming\_a\_psychedelic/](https://www.reddit.com/r/askatherapist/comments/1l21z4k/whats_the_typical_path_to_becoming_a_psychedelic/)  
42. The THRIVE Model of Psychedelic Integration: A Holistic Framework ..., accessed February 1, 2026, [https://www.researchgate.net/publication/396706393\_The\_THRIVE\_Model\_of\_Psychedelic\_Integration\_A\_Holistic\_Framework\_Bridging\_Indigenous\_Knowledge\_and\_Evidence-Based\_Practice](https://www.researchgate.net/publication/396706393_The_THRIVE_Model_of_Psychedelic_Integration_A_Holistic_Framework_Bridging_Indigenous_Knowledge_and_Evidence-Based_Practice)  
43. Luminello to SimplePractice: Why Practices Should ... \- Behave Health, accessed February 1, 2026, [https://behavehealth.com/blog/luminello-to-simplepractice-transition-group-practice-behavehealth](https://behavehealth.com/blog/luminello-to-simplepractice-transition-group-practice-behavehealth)  
44. Simple Practice vs Tebra vs Osmind vs Valant for Solo Practice, accessed February 1, 2026, [https://www.reddit.com/r/Psychiatry/comments/1cxa4m8/simple\_practice\_vs\_tebra\_vs\_osmind\_vs\_valant\_for/](https://www.reddit.com/r/Psychiatry/comments/1cxa4m8/simple_practice_vs_tebra_vs_osmind_vs_valant_for/)  
45. My company switched EMR systems : r/therapists \- Reddit, accessed February 1, 2026, [https://www.reddit.com/r/therapists/comments/1erp72n/my\_company\_switched\_emr\_systems/](https://www.reddit.com/r/therapists/comments/1erp72n/my_company_switched_emr_systems/)  
46. Starting Measurement Based Care Today Now \- Osmind, accessed February 1, 2026, [https://www.osmind.org/blog/measurement-based-care-starter-kit](https://www.osmind.org/blog/measurement-based-care-starter-kit)  
47. Top EHR Features for Evolving Psychedelic Medicine Practices, accessed February 1, 2026, [https://www.osmind.org/blog/top-5-ehr-features-for-evolving-psychedelic-practices](https://www.osmind.org/blog/top-5-ehr-features-for-evolving-psychedelic-practices)  
48. accessed February 1, 2026, [https://hub.jhu.edu/magazine/2022/fall/new-era-of-psychedelic-treatment/\#:\~:text=While%20some%20organizations%20have%20certification,Hopkins%20assistant%20professor%20of%20psychiatry.](https://hub.jhu.edu/magazine/2022/fall/new-era-of-psychedelic-treatment/#:~:text=While%20some%20organizations%20have%20certification,Hopkins%20assistant%20professor%20of%20psychiatry.)  
49. “This is you teaching you:” Exploring providers' perspectives on ..., accessed February 1, 2026, [https://pmc.ncbi.nlm.nih.gov/articles/PMC11361647/](https://pmc.ncbi.nlm.nih.gov/articles/PMC11361647/)  
50. PLOS ONE \- Research journals, accessed February 1, 2026, [https://journals.plos.org/plosone/article/file?type=printable\&id=10.1371/journal.pone.0306381](https://journals.plos.org/plosone/article/file?type=printable&id=10.1371/journal.pone.0306381)  
51. An Exploratory Study of Similarities and Differen, accessed February 1, 2026, [https://manifold.counseling.org/system/resource/1/b/d/1bd14083-9418-4e2e-ad76-b878d0f64579/attachment/bc8e26d37b5bcc10a3aba45ceab5d1b9.pdf](https://manifold.counseling.org/system/resource/1/b/d/1bd14083-9418-4e2e-ad76-b878d0f64579/attachment/bc8e26d37b5bcc10a3aba45ceab5d1b9.pdf)  
52. Psychedelic Therapy Abuse: My Experience with Aharon Grossbard, ..., accessed February 1, 2026, [https://medium.com/@willhall/psychedelic-therapy-abuse-my-experience-with-aharon-grossbard-francoise-bourzat-and-their-a1f0f6d06d64](https://medium.com/@willhall/psychedelic-therapy-abuse-my-experience-with-aharon-grossbard-francoise-bourzat-and-their-a1f0f6d06d64)  
53. Psychedelics Research: Evidenced-Based Messaging, Informed ..., accessed February 1, 2026, [https://www.hopkinsmedicine.org/news/articles/2025/02/psychedelics-research-evidenced-based-messaging-informed-consent-adverse-events-surveillance](https://www.hopkinsmedicine.org/news/articles/2025/02/psychedelics-research-evidenced-based-messaging-informed-consent-adverse-events-surveillance)  
54. Informed Consent to Psychedelic Treatment—A Work in Progress, accessed February 1, 2026, [https://www.ovid.com/journals/japs/pdf/10.1001/jamapsychiatry.2024.0124\~informed-consent-to-psychedelic-treatmenta-work-in-progress](https://www.ovid.com/journals/japs/pdf/10.1001/jamapsychiatry.2024.0124~informed-consent-to-psychedelic-treatmenta-work-in-progress)  
55. Ketamine-assisted psychotherapy in adolescents with multiple ..., accessed February 1, 2026, [https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2023.1141988/full](https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2023.1141988/full)  
56. INFORMED CONSENT FOR KETAMINE INFUSION THERAPY, accessed February 1, 2026, [https://www.flmindhealth.com/wp-content/uploads/2019/07/FMHC\_Consent-1.pdf](https://www.flmindhealth.com/wp-content/uploads/2019/07/FMHC_Consent-1.pdf)  
57. The Mystical Experience Questionnaire 4-Item and Challenging ..., accessed February 1, 2026, [https://pmc.ncbi.nlm.nih.gov/articles/PMC11658653/](https://pmc.ncbi.nlm.nih.gov/articles/PMC11658653/)  
58. The Watts Connectedness Scale: a new scale for measuring a sense ..., accessed February 1, 2026, [https://psychedelicnetwork.org.uk/emerging-research/the-watts-connectedness-scale-a-new-scale-for-measuring-a-sense-of-connectedness-to-self-others-and-world](https://psychedelicnetwork.org.uk/emerging-research/the-watts-connectedness-scale-a-new-scale-for-measuring-a-sense-of-connectedness-to-self-others-and-world)  
59. Therapeutic questions for first session : r/PsychedelicTherapy \- Reddit, accessed February 1, 2026, [https://www.reddit.com/r/PsychedelicTherapy/comments/18h6ftk/therapeutic\_questions\_for\_first\_session/](https://www.reddit.com/r/PsychedelicTherapy/comments/18h6ftk/therapeutic_questions_for_first_session/)  
60. Attitudes of psychedelic users regarding cost of treatment and non ..., accessed February 1, 2026, [https://www.researchgate.net/publication/381041329\_Attitudes\_of\_psychedelic\_users\_regarding\_cost\_of\_treatment\_and\_non-hallucinogenic\_alternatives](https://www.researchgate.net/publication/381041329_Attitudes_of_psychedelic_users_regarding_cost_of_treatment_and_non-hallucinogenic_alternatives)  
61. How is the PhD at Philosophy, Cosmology, and Consciousness ..., accessed February 1, 2026, [https://www.reddit.com/r/AcademicPhilosophy/comments/tvlia5/how\_is\_the\_phd\_at\_philosophy\_cosmology\_and/](https://www.reddit.com/r/AcademicPhilosophy/comments/tvlia5/how_is_the_phd_at_philosophy_cosmology_and/)  
62. Credentialed Clinicians Licensed to Provide Psychotherapy ..., accessed February 1, 2026, [https://www.brainfutures.org/wp-content/uploads/2025/04/A-Guide-to-CPT-and-HCPCS-Codes-for-Psychedelic-Assisted-Therapy\_Cheat-Sheets.pdf](https://www.brainfutures.org/wp-content/uploads/2025/04/A-Guide-to-CPT-and-HCPCS-Codes-for-Psychedelic-Assisted-Therapy_Cheat-Sheets.pdf)  
63. Gaps in US Psychedelic Policy and How to Close Them, accessed February 1, 2026, [https://www.researchgate.net/publication/397381176\_Gaps\_in\_US\_Psychedelic\_Policy\_and\_How\_to\_Close\_Them](https://www.researchgate.net/publication/397381176_Gaps_in_US_Psychedelic_Policy_and_How_to_Close_Them)  
64. How To Avoid Burnout As A Psychedelic Practitioner With Dr. Steven ..., accessed February 1, 2026, [https://www.youtube.com/watch?v=EspTYWs6MrQ](https://www.youtube.com/watch?v=EspTYWs6MrQ)  
65. Psychedelic iatrogenic structural dissociation: an exploratory ..., accessed February 1, 2026, [https://www.frontiersin.org/journals/psychology/articles/10.3389/fpsyg.2025.1528253/full](https://www.frontiersin.org/journals/psychology/articles/10.3389/fpsyg.2025.1528253/full)  
66. Effects of Psychedelics in Older Adults: A Prospective Cohort Study, accessed February 1, 2026, [https://escholarship.org/content/qt6s6926n0/qt6s6926n0\_noSplash\_a85a798772f0ec703b424cbc7905c123.pdf](https://escholarship.org/content/qt6s6926n0/qt6s6926n0_noSplash_a85a798772f0ec703b424cbc7905c123.pdf)  
67. Psychedelic Group Based Integration: Ethical Assessment and Initial ..., accessed February 1, 2026, [https://www.researchgate.net/publication/380728906\_Psychedelic\_Group\_Based\_Integration\_Ethical\_Assessment\_and\_Initial\_Recommendations](https://www.researchgate.net/publication/380728906_Psychedelic_Group_Based_Integration_Ethical_Assessment_and_Initial_Recommendations)  
68. Can pragmatic research, real-world data and digital technologies aid ..., accessed February 1, 2026, [https://pmc.ncbi.nlm.nih.gov/articles/PMC8801625/](https://pmc.ncbi.nlm.nih.gov/articles/PMC8801625/)  
69. Ayahuasca Users in Estonia: Ceremonial Practices, Subjective Long ..., accessed February 1, 2026, [https://www.researchgate.net/publication/340718698\_Ayahuasca\_Users\_in\_Estonia\_Ceremonial\_Practices\_Subjective\_Long-Term\_Effects\_Mental\_Health\_and\_Quality\_of\_Life](https://www.researchgate.net/publication/340718698_Ayahuasca_Users_in_Estonia_Ceremonial_Practices_Subjective_Long-Term_Effects_Mental_Health_and_Quality_of_Life)  
70. Psychedelic Harm Reduction and Integration \- Numinus, accessed February 1, 2026, [https://numinusnetwork.com/courses/psychedelic-harm-reduction-and-integration-introduction-for-practitioners/](https://numinusnetwork.com/courses/psychedelic-harm-reduction-and-integration-introduction-for-practitioners/)